Csenge Advisory Group United Therapeutics Corp Transaction History
Csenge Advisory Group
- $1.77 Billion
- Q1 2024
A detailed history of Csenge Advisory Group transactions in United Therapeutics Corp stock. As of the latest transaction made, Csenge Advisory Group holds 1,457 shares of UTHR stock, worth $464,127. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,457
Previous 1,434
1.6%
Holding current value
$464,127
Previous $315,000
6.03%
% of portfolio
0.02%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding UTHR
# of Institutions
561Shares Held
43.1MCall Options Held
501KPut Options Held
529K-
Black Rock Inc. New York, NY5.57MShares$1.77 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.68MShares$1.49 Billion0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.41MShares$1.09 Billion0.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$911 Million7.91% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.15MShares$685 Million0.78% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14.5B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...